What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Immune system
- Tuberculosis
Robert S. Wallis spends much of his time researching Immunology, Tuberculosis, Mycobacterium tuberculosis, Tumor necrosis factor alpha and Infliximab.
Robert S. Wallis frequently studies issues relating to Tuberculin and Immunology.
His Tuberculosis research includes themes of Virology, Acquired immunodeficiency syndrome, Intensive care medicine, Immunopathology and Risk factor.
Robert S. Wallis interconnects Culture conversion, Cellular immunity, Lung injury and Microbiology in the investigation of issues within Mycobacterium tuberculosis.
His Tumor necrosis factor alpha research incorporates themes from Immune system, Antibody and Cytokine.
His work deals with themes such as Paradoxical reaction, Etanercept and Monoclonal antibody, which intersect with Infliximab.
His most cited work include:
- Granulomatous Infectious Diseases Associated with Tumor Necrosis Factor Antagonists (826 citations)
- The risk of tuberculosis related to tumour necrosis factor antagonist therapies: a TBNET consensus statement (359 citations)
- Biomarkers and diagnostics for tuberculosis: progress, needs, and translation into practice (358 citations)
What are the main themes of his work throughout his whole career to date?
His primary scientific interests are in Tuberculosis, Immunology, Mycobacterium tuberculosis, Tumor necrosis factor alpha and Internal medicine.
His studies deal with areas such as Clinical trial, Virology and Intensive care medicine as well as Tuberculosis.
As a part of the same scientific study, Robert S. Wallis usually deals with the Immunology, concentrating on Tuberculin and frequently concerns with Antimycobacterial.
His work investigates the relationship between Mycobacterium tuberculosis and topics such as Microbiology that intersect with problems in Mycobacterium bovis.
His study in Tumor necrosis factor alpha is interdisciplinary in nature, drawing from both Necrosis, Blockade, Rheumatoid arthritis and Monoclonal antibody.
In his research, Pyrazinamide is intimately related to Surgery, which falls under the overarching field of Internal medicine.
He most often published in these fields:
- Tuberculosis (73.62%)
- Immunology (70.55%)
- Mycobacterium tuberculosis (42.33%)
What were the highlights of his more recent work (between 2013-2021)?
- Tuberculosis (73.62%)
- Immunology (70.55%)
- Internal medicine (18.40%)
In recent papers he was focusing on the following fields of study:
His main research concerns Tuberculosis, Immunology, Internal medicine, Mycobacterium tuberculosis and Sputum culture.
His Tuberculosis study combines topics from a wide range of disciplines, such as Clinical trial, Intensive care medicine, Pulmonary function testing, Lung injury and Pharmacology.
Robert S. Wallis combines Immunology and In patient in his research.
Robert S. Wallis has included themes like Gastroenterology and Drug in his Internal medicine study.
The study incorporates disciplines such as Whole blood, Ex vivo, Antibiotics, Immune system and Blood proteins in addition to Mycobacterium tuberculosis.
His research in Sputum culture focuses on subjects like Biomarker, which are connected to Drug development and Microbiology.
Between 2013 and 2021, his most popular works were:
- Advancing host-directed therapy for tuberculosis (190 citations)
- Tuberculosis—advances in development of new drugs, treatment regimens, host-directed therapies, and biomarkers (171 citations)
- High-dose rifampicin, moxifloxacin, and SQ109 for treating tuberculosis: a multi-arm, multi-stage randomised controlled trial (167 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Immune system
- Tuberculosis
Robert S. Wallis focuses on Tuberculosis, Mycobacterium tuberculosis, Immunology, Clinical trial and Internal medicine.
His research in Tuberculosis intersects with topics in Infectious disease, Immune system, Intensive care medicine, Varicella zoster virus and Drug resistance.
His Drug resistance study integrates concerns from other disciplines, such as Antimicrobial, Malaria and Pharmacology.
His biological study deals with issues like Lung injury, which deal with fields such as Antimicrobial peptide production, Immunotherapy, Macrophage, Effector and Inflammation.
In most of his Immunology studies, his work intersects topics such as Adverse effect.
The Internal medicine study which covers Sputum that intersects with Alanine transaminase, Blood plasma, Blood Bactericidal Activity and Gastroenterology.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
